NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in ASP Isotopes Inc. ("ASP Isotopes Inc." or the "Company") (NASDAQ: ASPI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ASP Isotopes Inc. investors who were adversely affected by alleged securities fraud between October 30, 2024 and November 26, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/asp ...

LOS ANGELES, Dec. 11, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ: ASPI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between October 30, 2024 and November 26, 2024, inclusive (the "Class Per ...

SAN DIEGO, Dec. 5, 2024 /PRNewswire/ -- Robbins LLP informs investors that a class action was filed on behalf of persons and entities that purchased or otherwise acquired ASP Isotopes Inc. (NASDAQ: ASPI) securities between October 30, 2024 and November 26, 2024. ASP Isotopes is a development stage advanced materials company focused on the production, enrichment, and sale of isotopes.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allegations: Rob ...

SAN FRANCISCO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) and certain of its most senior executives are now entangled in a securities class action, alleging the company deceived investors by making false and misleading statements about its advanced nuclear fuel technologies. Hagens Berman urges investors in ASP Isotopes who suffered substantial losses to submit your losses now. Class Period: Oct. 30, 2024 – Nov. 26, 2024Lead Plaintiff Deadline: Feb. 3, 2025Visit: www.hbsslaw.com/inve ...

NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ:ASPI) on behalf of ASP Isotopes stockholders. Our investigation concerns whether ASP Isotopes has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. A report from Fuzzy Panda Research alleged serious conc ...

WASHINGTON, Dec. 02, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it will host an Investor Access Event in South Africa from January 14-16, 2025. All investors are invited to request a registration to attend the Investor Access Event. ASP Isotopes values transparency and open communication with ...

文章核心观点 - ASP Isotopes (ASPI) 股价在2024年11月26日盘中暴跌30%，原因是Fuzzy Panda Research发布报告指控ASPI使用过时设备并秘密支付股票推广费用 [1][3] 公司调查 - Hagens Berman 已开始对ASPI的指控进行调查，重点关注ASPI关于其Aerodynamic Separation Process (ASP) 技术和Quantum Enrichment技术的披露 [2] - 调查由Reed Kathrein领导，关注ASPI是否误导投资者关于其技术的商业前景 [4] 报告指控 - Fuzzy Panda Research 报告称ASPI使用旧的、被忽视的激光浓缩技术伪装成新的、尖端的铀浓缩公司 [3] - 报告指出ASPI雇佣多人推广其股票，前Centrus高管评估其技术为“几乎毫无价值”，其他科学家认为其技术“不可能扩展” [3] 股价影响 - 受Fuzzy Panda Research报告影响，ASPI股价在单个交易日内下跌23% [3] 投资者行动 - Hagens Berman 鼓励在ASPI遭受重大损失的投资者提交损失，提供联系方式和网站 [2] - 提供SEC举报人计划信息，举报人提供原始信息可获得最高30%的SEC成功追回奖励 [4] 公司背景 - Hagens Berman 是一家全球原告权利复杂诉讼公司，专注于企业问责，已在该领域获得超过29亿美元的成功 [5]

公司回应 - ASP Isotopes Inc. 对 Fuzzy Panda Research 发布的做空报告进行了回应，认为报告包含不准确的猜测和误导性信息，旨在误导投资者对公司技术、领导层和未来增长的看法 [1][2] 公司业务 - 公司正在南非建设三个同位素浓缩设施，第一个设施计划用于医疗保健和农业化学品的碳-14浓缩，第二个设施计划用于人工智能和量子计算的硅-28浓缩，第三个设施计划用于放射肿瘤治疗的关键原材料镱-176的浓缩 [3] - 公司专注于开发和商业化高浓缩同位素，主要用于医疗保健和技术行业，并计划使用正在开发的量子浓缩技术为核能行业浓缩同位素 [5] 行业需求 - 行业对多种同位素的需求不断增长，包括用于量子计算的硅-28，用于新兴医疗应用的钼-100、钼-98、锌-68、镱-176和镍-64，以及用于绿色能源应用的氯-37、锂-6、锂-7和铀-235 [6] 公司透明度 - 公司重视透明度和开放沟通，将于2024年11月27日上午10点（东部标准时间）与Canaccord Genuity的分析师George Gianarikas一起举办炉边谈话，讨论公司的发展 [4] 公司简介 - ASP Isotopes Inc. 是一家处于发展阶段的先进材料公司，致力于开发用于多个行业的同位素生产技术和工艺，主要使用其专有的气动分离过程（ASP技术） [5] 未来展望 - 公司未来的展望包括对同位素浓缩技术的市场需求、同位素供应的启动以及公司未来的业务计划和战略 [7]

请提供关键要点内容。

WASHINGTON, Oct. 30, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it has entered into a term sheet with TerraPower, a nuclear innovation company and advanced nuclear energy developer, related to the construction of a uranium enrichment facility capable of producing High Assay Low-Enriched Urani ...